Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicin

Adrian Kruit, Carlos Reyes-Moreno, Donald W.W. Newling, Albert Geldof, Michael Koutsilieris

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objectives: We evaluated the effects of irradiation, doxorubicin and dexamethasone on human PC-3 prostate cancer cells, investigating whether dexamethasone and doxorubicin can alter the irradiation cytotoxicity of PC-3 cells. Methods: We used the human PC-3 prostate cancer cells, analyzing cell growth with trypan blue exclusion, indices of the cell cycle with flow cytometry and apoptosis with flow cytometry and analysis of DNA fragmentation on simple agarose gel. Results: Doxorubicin (100 nM) arrested cell cycle at the G2/M phase, decreased cell growth and produced apoptosis of PC-3 cells in a time-dependent manner. Dexamethasone (100 nM) increased the distribution of PC-3 cells at G0/G1 phase in the cell cycle, exerting an inhibitory effect on the proliferation of PC-3 cells after 48 and 72 hr, but it did not produce apoptosis. Irradiation (4Gy) initially arrested cells at the G2/M phase in the cell cycle (24 hr) which was gradually overcome and the PC-3 cells were shifted into G0/G1 phase or apoptosis after 48 and 72 hr. Irradiation decreased the PC-3 cell growth by 40-50% after 48 and 72 hr, respectively. Treatment with doxorubicin (100 nM) for 24, 48, and 72 hr after irradiation potentiated irradiation cytotoxicity of PC-3 cells. Dexamethasone treatment 24 hr before and 24, 48 and 72 hr after irradiation increased the number of surviving PC-3 cells and partially neutralized the irradiation effects on cell cycle. Conclusion: Doxorubicin potentiated while dexamethasone partially reversed the irradiation cytotoxicity of PC-3 cells. These data may be of clinical importance for the treatment of hormone refractory prostate cancer.

Original languageEnglish
Pages (from-to)3153-3156
Number of pages4
JournalAnticancer Research
Volume19
Issue number4 B
Publication statusPublished - 1 Dec 1999

Cite this

Kruit, A., Reyes-Moreno, C., Newling, D. W. W., Geldof, A., & Koutsilieris, M. (1999). Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicin. Anticancer Research, 19(4 B), 3153-3156.
Kruit, Adrian ; Reyes-Moreno, Carlos ; Newling, Donald W.W. ; Geldof, Albert ; Koutsilieris, Michael. / Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicin. In: Anticancer Research. 1999 ; Vol. 19, No. 4 B. pp. 3153-3156.
@article{833c99aa42da4053ae54ad574df63d43,
title = "Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicin",
abstract = "Objectives: We evaluated the effects of irradiation, doxorubicin and dexamethasone on human PC-3 prostate cancer cells, investigating whether dexamethasone and doxorubicin can alter the irradiation cytotoxicity of PC-3 cells. Methods: We used the human PC-3 prostate cancer cells, analyzing cell growth with trypan blue exclusion, indices of the cell cycle with flow cytometry and apoptosis with flow cytometry and analysis of DNA fragmentation on simple agarose gel. Results: Doxorubicin (100 nM) arrested cell cycle at the G2/M phase, decreased cell growth and produced apoptosis of PC-3 cells in a time-dependent manner. Dexamethasone (100 nM) increased the distribution of PC-3 cells at G0/G1 phase in the cell cycle, exerting an inhibitory effect on the proliferation of PC-3 cells after 48 and 72 hr, but it did not produce apoptosis. Irradiation (4Gy) initially arrested cells at the G2/M phase in the cell cycle (24 hr) which was gradually overcome and the PC-3 cells were shifted into G0/G1 phase or apoptosis after 48 and 72 hr. Irradiation decreased the PC-3 cell growth by 40-50{\%} after 48 and 72 hr, respectively. Treatment with doxorubicin (100 nM) for 24, 48, and 72 hr after irradiation potentiated irradiation cytotoxicity of PC-3 cells. Dexamethasone treatment 24 hr before and 24, 48 and 72 hr after irradiation increased the number of surviving PC-3 cells and partially neutralized the irradiation effects on cell cycle. Conclusion: Doxorubicin potentiated while dexamethasone partially reversed the irradiation cytotoxicity of PC-3 cells. These data may be of clinical importance for the treatment of hormone refractory prostate cancer.",
keywords = "Combination therapy, Doxorubicin, Glucocorticoids, Irradiation, Prostate cancer cells",
author = "Adrian Kruit and Carlos Reyes-Moreno and Newling, {Donald W.W.} and Albert Geldof and Michael Koutsilieris",
year = "1999",
month = "12",
day = "1",
language = "English",
volume = "19",
pages = "3153--3156",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4 B",

}

Kruit, A, Reyes-Moreno, C, Newling, DWW, Geldof, A & Koutsilieris, M 1999, 'Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicin' Anticancer Research, vol. 19, no. 4 B, pp. 3153-3156.

Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicin. / Kruit, Adrian; Reyes-Moreno, Carlos; Newling, Donald W.W.; Geldof, Albert; Koutsilieris, Michael.

In: Anticancer Research, Vol. 19, No. 4 B, 01.12.1999, p. 3153-3156.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicin

AU - Kruit, Adrian

AU - Reyes-Moreno, Carlos

AU - Newling, Donald W.W.

AU - Geldof, Albert

AU - Koutsilieris, Michael

PY - 1999/12/1

Y1 - 1999/12/1

N2 - Objectives: We evaluated the effects of irradiation, doxorubicin and dexamethasone on human PC-3 prostate cancer cells, investigating whether dexamethasone and doxorubicin can alter the irradiation cytotoxicity of PC-3 cells. Methods: We used the human PC-3 prostate cancer cells, analyzing cell growth with trypan blue exclusion, indices of the cell cycle with flow cytometry and apoptosis with flow cytometry and analysis of DNA fragmentation on simple agarose gel. Results: Doxorubicin (100 nM) arrested cell cycle at the G2/M phase, decreased cell growth and produced apoptosis of PC-3 cells in a time-dependent manner. Dexamethasone (100 nM) increased the distribution of PC-3 cells at G0/G1 phase in the cell cycle, exerting an inhibitory effect on the proliferation of PC-3 cells after 48 and 72 hr, but it did not produce apoptosis. Irradiation (4Gy) initially arrested cells at the G2/M phase in the cell cycle (24 hr) which was gradually overcome and the PC-3 cells were shifted into G0/G1 phase or apoptosis after 48 and 72 hr. Irradiation decreased the PC-3 cell growth by 40-50% after 48 and 72 hr, respectively. Treatment with doxorubicin (100 nM) for 24, 48, and 72 hr after irradiation potentiated irradiation cytotoxicity of PC-3 cells. Dexamethasone treatment 24 hr before and 24, 48 and 72 hr after irradiation increased the number of surviving PC-3 cells and partially neutralized the irradiation effects on cell cycle. Conclusion: Doxorubicin potentiated while dexamethasone partially reversed the irradiation cytotoxicity of PC-3 cells. These data may be of clinical importance for the treatment of hormone refractory prostate cancer.

AB - Objectives: We evaluated the effects of irradiation, doxorubicin and dexamethasone on human PC-3 prostate cancer cells, investigating whether dexamethasone and doxorubicin can alter the irradiation cytotoxicity of PC-3 cells. Methods: We used the human PC-3 prostate cancer cells, analyzing cell growth with trypan blue exclusion, indices of the cell cycle with flow cytometry and apoptosis with flow cytometry and analysis of DNA fragmentation on simple agarose gel. Results: Doxorubicin (100 nM) arrested cell cycle at the G2/M phase, decreased cell growth and produced apoptosis of PC-3 cells in a time-dependent manner. Dexamethasone (100 nM) increased the distribution of PC-3 cells at G0/G1 phase in the cell cycle, exerting an inhibitory effect on the proliferation of PC-3 cells after 48 and 72 hr, but it did not produce apoptosis. Irradiation (4Gy) initially arrested cells at the G2/M phase in the cell cycle (24 hr) which was gradually overcome and the PC-3 cells were shifted into G0/G1 phase or apoptosis after 48 and 72 hr. Irradiation decreased the PC-3 cell growth by 40-50% after 48 and 72 hr, respectively. Treatment with doxorubicin (100 nM) for 24, 48, and 72 hr after irradiation potentiated irradiation cytotoxicity of PC-3 cells. Dexamethasone treatment 24 hr before and 24, 48 and 72 hr after irradiation increased the number of surviving PC-3 cells and partially neutralized the irradiation effects on cell cycle. Conclusion: Doxorubicin potentiated while dexamethasone partially reversed the irradiation cytotoxicity of PC-3 cells. These data may be of clinical importance for the treatment of hormone refractory prostate cancer.

KW - Combination therapy

KW - Doxorubicin

KW - Glucocorticoids

KW - Irradiation

KW - Prostate cancer cells

UR - http://www.scopus.com/inward/record.url?scp=0033428326&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 3153

EP - 3156

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4 B

ER -